Home Correction trading Revance (RVNC) drops 0.13% in Light Trading on October 21

Revance (RVNC) drops 0.13% in Light Trading on October 21



Today, shares of Revance Therapeutics Inc Inc (NASDAQ: RVNC) fell $ 0.02, down 0.13%. Revance opened at $ 15.70 before trading between $ 16.91 and $ 15.35 throughout Thursday’s session. Activity saw Revance’s market capitalization drop to $ 1,132,036,356 on 1,834,808 stocks, below their 30-day average of 2,063,721.

About Revance Therapeutics Inc

Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection. DaxibotulinumtoxinA for Injection combines a proprietary stabilizing peptide excipient with a highly purified botulinum toxin that does not contain components of human or animal origin. Revance has successfully completed a Phase 3 program for DaxibotulinumtoxinA for injection in glabellar lines (frowning) and is seeking regulatory approval in the United States. Revance is also evaluating DaxibotulinumtoxinA for injection in the upper part of the face, including glabellar lines, forehead lines and crow’s feet, as well as in two therapeutic indications – cervical dystonia and upper limb spasticity in adults. . To accompany DaxibotulinumtoxinA for Injection, Revance has a unique portfolio of premium products and services for American aesthetic practices, including exclusive distribution rights in the United States of the RHA® collection of dermal fillers, the first and the only line of FDA-approved fillers for dynamic correction of facial wrinkles and creases, and the HintMD fintech platform, which provides an integrated smart payment solution that supports practice management aesthetics, economy of practice and fidelity to practice. Revance has also partnered with Viatris (formerly Mylan NV) to develop a biosimilar to BOTOX®, which would compete in the current market for short-acting neuromodulators. Revance is committed to making a difference by transforming patient experiences.

Visit the Revance Therapeutics Inc profile for more information.

The daily solution

Here is a selection of trends from our newsletter, The Daily Fix, which captured the attention of readers. Click here to subscribe and get The Daily Fix delivered straight to your inbox.

Keep Your Friends Close, But Your Enemies Closer – Part I

Revenge is amazing human activity. In business, kicking opponents when they’re down comes with territory. As Huawei battles US government sanctions, Xiaomi steps in to introduce competing products and gain market share. The former Communists quickly discovered the market economy. No Facebook employee (NASDAQ: FB) is asking the giant to take it easy on Myspace. Do you remember Myspace? No Apple (NASDAQ: AAPL) executive is lending a hand to Motorola, which is even more difficult to remember. This new series takes a look at some tasty examples of ROI.


Breaking down the supply chain bottleneck

Since the onset of the global pandemic, historically low interest rates and government spending have inhibited saving and encouraged borrowing and spending to boost the economy during difficult times. The US Federal Reserve and the government injected much more liquidity into the financial system than during the global financial crisis of 2008. We have seen an increase in inflationary pressures due to the stimulus. In addition, the unintended consequences of the pandemic created shortages and supply chain bottlenecks that only exacerbated the rise in prices.


Walgreens invests an additional $ 5.2 billion in primary care provider VillageMD

Walgreens Boots Alliance Inc (Nasdaq: WBA) will invest $ 5.2 billion in primary care provider VillageMD as part of the drugstore chain’s plan to open more co-located practices at its drugstores across the United States.

The investment announced Thursday brings the Deerfield, Illinois-based chain’s stake in VillageMD to 63%, from the 30% it acquired in July 2020.


About the Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, as well as the listing of stocks and options. The Nasdaq is the world’s largest stock exchange for options volume and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information about Revance Therapeutics Inc and keep up with the latest company updates, you can visit the Company Profile page here: Revance Therapeutics Inc. Profile For More Financial Markets Information , be sure to visit Equities News. Also, don’t forget to sign up for the Daily Fix to get the best stories delivered to your inbox 5 days a week.

Sources: The chart is provided by TradingView on the basis of prices delayed by 15 minutes. All other data is provided by IEX Cloud as of 8:05 p.m. ET on the day of publication.

The views and opinions expressed in this article are those of the authors and do not represent the views of equities.com. Readers should not take the author’s statements as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please visit: http://www.equities.com/disclaimer

Unemployment claims fall to 290,000 – lowest in 19 months

Paul Tudor Jones calls inflation “biggest threat” to financial markets

FDA extends authorization to use booster doses for COVID-19 vaccines

McDonald’s to bring new plant-based burger to U.S. restaurants by Beyond Meat

Walgreens invests an additional $ 5.2 billion in primary care provider VillageMD

JPMorgan misses third quarter revenue, beats profit estimates with one-off items

BlackRock beats third quarter earnings estimates, but asset growth flattens



Please enter your comment!
Please enter your name here